1. Market Research
  2. > Cancer Industry

Prostate Cancer Industry, January 2017 Market Reports from Top Publishers

You might be interested in: Molecular Diagnostic, Cancer, Diagnostics, Therapy, Biopsy, Hormone, Magnetic Resonance Imaging, Cancer Diagnostic, Medical Robotics, Vaccine, Biomarker, Cancer Biomarker, Urology, Genetic, Infectious Disease, Oncology, Ultrasound, Biosimilar, Cancer Vaccine, Clinical Laboratory.


 
1-10 of 91 reports for Prostate Cancer

Purchase Reports From Reputable Market Research Publishers

 Metastatic Prostate Cancer-Pipeline Insights, 2017

Metastatic Prostate Cancer-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Metastatic Prostate Cancer-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Metastatic Prostate Cancer. ...

Prostate cancer - Epidemiology Forecast To 2023

Prostate cancer - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Prostate cancer - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Prostate cancer in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). ...

 Metastatic Hormone Refractory Prostate Cancer-Pipeline Insights, 2017

Metastatic Hormone Refractory Prostate Cancer-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Metastatic Hormone Refractory Prostate Cancer-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Metastatic ...

Prostate Cancer - Pipeline Review, H2 2016

Prostate Cancer - Pipeline Review, H2 2016

  • $ 2500
  • Company report
  • December 2016
  • by Global Markets Direct

Prostate Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer – Pipeline Review, H2 2016, provides an overview ...

Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by Global Data

Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, ...

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline ...

Global Prostate Cancer Drugs Market 2016-2020

Global Prostate Cancer Drugs Market 2016-2020

  • $ 2500
  • Industry report
  • November 2016
  • by Infiniti Research Limited

About Prostate Cancer Drugs Prostate cancer is the cancer of prostate gland. According to CDC, it is one of the leading cause of cancer death in men across the races in the US. According to the Urology ...

Global and Chinese Prostate Cancer Therapeutics Industry, 2016 Market Research Report

Global and Chinese Prostate Cancer Therapeutics Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Prostate Cancer Therapeutics Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Prostate Cancer Therapeutics ...

Global Prostate Cancer Partnering 2010 to 2016

Global Prostate Cancer Partnering 2010 to 2016

  • $ 1495
  • Industry report
  • November 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. - ...

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hormone ...

About 8100 reports for Prostate Cancer

Download Unlimited Documents from Trusted Public Sources

Prostate Cancer Statistics in Canada

  • November 2015
    128 pages
  • Prostate Cancer  

    Therapy  

  • Canada  

    North America  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.